_id

690f37f1ccc777a4e85d1824

Ticker

BPTH

Name

Bio Path Holdings Inc

Exchange

OTCQX

Address

4710 Bellaire Boulevard, Bellaire, TX, United States, 77401

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.biopathholdings.com

Description

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the DNAbilize, a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body's enzymes when circulating in vivo, incorporated inside of a lipid bilayer having neutral charge. The company's lead drug candidate is the Prexigebersen (BP1001), which is in phase 2 clinical trial for the treatment of untreated acute myeloid leukemia (AML). It is also developing BP1001-A, which is in phase 1 clinical trial for treatment of solid tumors, including ovarian, endometrial and pancreatic cancer, as well as in preclinical trial to treat obesity and related metabolic diseases; Liposomal Bcl-2 (BP1002), which is in phase 1 clinical trial to treat refractory/relapsed lymphoma and refractory/relapsed chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003), which is preclinical trial for the treatment of pancreatic cancer, non-small cell lung cancer, and AML. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

Last Close

0.0897

Volume

13841

Current Price

0.0751

Change

-16.276477146042364

Last Updated

2025-11-28T13:06:13.887Z

Image

data:image/webp;base64,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

Ipo Date

2008-03-04T00:00:00.000Z

Market Cap

581552

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

4

Target Price

2

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

4562000

Operating Income

-4562000

Interest Expense

35000

Pretax Income

-4597000

Net Income

-4597000

Eps

-0.5533292921959024

Dividends Per Share

-

Shares Outstanding

8307892

Income Tax Expense

-

EBITDA

-

Operating Margin

-

Total Other Income Expense Net

-

Cash

0

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

680000

Property Plant Equipment

66000

Total Assets

746000

Payables

3479000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

7904000

Equity

-7158000

Depreciation

41000

Change In Working Capital

4210000

Cash From Operations

-283000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

161000

Net Change In Cash

-122000

PE

-

PB

-0.0871643879854708

ROE

64.2218496786812

ROA

-616.2198391420911

FCF

-283000

Fcf Percent

-

Piotroski FScore

1

Health Score

39

Deep Value Investing Score

0.5

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

2

Growth Investing Score

2

Momentum Investing Score

2

Net Net Investing Score

0.5

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

4562000

Quarters > 0 > income Statement > operating Income

-4562000

Quarters > 0 > income Statement > interest Expense

35000

Quarters > 0 > income Statement > pretax Income

-4597000

Quarters > 0 > income Statement > net Income

-4597000

Quarters > 0 > income Statement > eps

-0.5533292921959024

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

8307892

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-

Quarters > 0 > balance Sheet > cash

0

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

680000

Quarters > 0 > balance Sheet > property Plant Equipment

66000

Quarters > 0 > balance Sheet > total Assets

746000

Quarters > 0 > balance Sheet > payables

3479000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

7904000

Quarters > 0 > balance Sheet > equity

-7158000

Quarters > 0 > cash Flow > net Income

-4597000

Quarters > 0 > cash Flow > depreciation

41000

Quarters > 0 > cash Flow > change In Working Capital

4210000

Quarters > 0 > cash Flow > cash From Operations

-283000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

161000

Quarters > 0 > cash Flow > net Change In Cash

-122000

Quarters > 0 > ratios > PE

-0.5533292921959024

Quarters > 0 > ratios > PB

-0.0871643879854708

Quarters > 0 > ratios > ROE

64.2218496786812

Quarters > 0 > ratios > ROA

-616.2198391420911

Quarters > 0 > ratios > FCF

-283000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

39

Quarters > 1 > quarter

2025-03-31

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

3241000

Quarters > 1 > income Statement > operating Income

-3241000

Quarters > 1 > income Statement > interest Expense

5000

Quarters > 1 > income Statement > pretax Income

-2852000

Quarters > 1 > income Statement > net Income

-2852000

Quarters > 1 > income Statement > eps

-0.3432880446688522

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

8307892

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

394000

Quarters > 1 > balance Sheet > cash

122000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

2120000

Quarters > 1 > balance Sheet > property Plant Equipment

75000

Quarters > 1 > balance Sheet > total Assets

2195000

Quarters > 1 > balance Sheet > payables

2438000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

4784000

Quarters > 1 > balance Sheet > equity

-2589000

Quarters > 1 > cash Flow > net Income

-2852000

Quarters > 1 > cash Flow > depreciation

32000

Quarters > 1 > cash Flow > change In Working Capital

1788000

Quarters > 1 > cash Flow > cash From Operations

-1313000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

262000

Quarters > 1 > cash Flow > net Change In Cash

-1051000

Quarters > 1 > ratios > PE

-0.3432880446688522

Quarters > 1 > ratios > PB

-0.24098983746620317

Quarters > 1 > ratios > ROE

110.15836230204712

Quarters > 1 > ratios > ROA

-129.93166287015944

Quarters > 1 > ratios > FCF

-1313000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

39

Quarters > 2 > quarter

2024-12-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

2625000

Quarters > 2 > income Statement > operating Income

-2625000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-2753000

Quarters > 2 > income Statement > net Income

-2753000

Quarters > 2 > income Statement > eps

-0.4772974251251584

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

5767892

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-132000

Quarters > 2 > balance Sheet > cash

1173000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

3776000

Quarters > 2 > balance Sheet > property Plant Equipment

107000

Quarters > 2 > balance Sheet > total Assets

3883000

Quarters > 2 > balance Sheet > payables

1274000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

3729000

Quarters > 2 > balance Sheet > equity

154000

Quarters > 2 > cash Flow > net Income

-2753000

Quarters > 2 > cash Flow > depreciation

47000

Quarters > 2 > cash Flow > change In Working Capital

-434000

Quarters > 2 > cash Flow > cash From Operations

-2881000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

3492000

Quarters > 2 > cash Flow > net Change In Cash

611000

Quarters > 2 > ratios > PE

-0.4772974251251584

Quarters > 2 > ratios > PB

2.812783696103896

Quarters > 2 > ratios > ROE

-1787.662337662338

Quarters > 2 > ratios > ROA

-70.89878959567345

Quarters > 2 > ratios > FCF

-2881000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

24

Quarters > 3 > quarter

2024-09-30

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

2634000

Quarters > 3 > income Statement > operating Income

-2634000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-2115000

Quarters > 3 > income Statement > net Income

-2115000

Quarters > 3 > income Statement > eps

-0.7010275107722903

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

3017000

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-2628000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

519000

Quarters > 3 > balance Sheet > cash

562000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

2899000

Quarters > 3 > balance Sheet > property Plant Equipment

66000

Quarters > 3 > balance Sheet > total Assets

2965000

Quarters > 3 > balance Sheet > payables

1036000

Quarters > 3 > balance Sheet > short Term Debt

26000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

3677000

Quarters > 3 > balance Sheet > equity

-712000

Quarters > 3 > cash Flow > net Income

-2115000

Quarters > 3 > cash Flow > depreciation

33000

Quarters > 3 > cash Flow > change In Working Capital

-959000

Quarters > 3 > cash Flow > cash From Operations

-3428000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-16000

Quarters > 3 > cash Flow > net Change In Cash

-3444000

Quarters > 3 > ratios > PE

-0.7010275107722903

Quarters > 3 > ratios > PB

-0.318225702247191

Quarters > 3 > ratios > ROE

297.0505617977528

Quarters > 3 > ratios > ROA

-71.33220910623946

Quarters > 3 > ratios > FCF

-3428000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

38

Valuation > metrics > PE

-0.5533292921959024

Valuation > metrics > PB

-0.0871643879854708

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

64.2218496786812

Profitability > metrics > ROA

-676.029411764706

Profitability > final Score

55

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-130.34285714285716

Risk > final Score

-491

Risk > verdict

High

Liquidity > metrics > Current Ratio

0.19545846507617132

Liquidity > metrics > Quick Ratio

0.19545846507617132

Liquidity > final Score

20

Liquidity > verdict

Weak

Prev Valuations > 0

50

Prev Valuations > 1

80

Prev Valuations > 2

50

Prev Profitabilities > 0

55

Prev Profitabilities > 1

15

Prev Profitabilities > 2

55

Prev Risks > 0

-2563

Prev Risks > 1

-74

Prev Risks > 2

9

Prev Liquidities > 0

53

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:17:45.983Z